Zihao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zihao Wang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jun (Joelle) Wang
Hong Kong Baptist University
2 shared publications - Zhaoxiang Bian
Vincent V.C Woo Chinese Medicine Clinical Research Institute, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China
2 shared publications Afagh Rastmanesh
Department of Materials Science and Engineering, School of Engineering, Shiraz University, Shiraz, Iran
1 shared publication- Catherine Hong Huan Hor
Department of Chemistry, Faculty of Science, Hong Kong Baptist University, Hong Kong SAR
1 shared publication - Hai-Tao Xiao
Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong 518055, China
1 shared publication Haitao Xiao
School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518066, China
1 shared publication
Latest Publications
- Open Access
- 3 June 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (22) , eabm9603
Asymmetric synthesis of flavanols via Cu-catalyzed kinetic resolution of chromenes and their anti-inflammatory activity
Flavanols are privileged heterocyclic compounds in medicinal chemistry. It is notable to develop an efficient and straightforward protocol for accessing chiral flavanols with precise control of the stereocenters. Here, a highly efficient kinetic resolution of chromenes was reported via Cu-catalyzed asymmetric hydroboration. This previously unidentified approach features a one-step synthesis of chiral flavan-3-ols containing two vicinal stereogenic centers via a highly efficient kinetic resolution ( s factor up to 1060, >99% ee for most products). In addition, the anti-inflammation effects of these diversified flavan-3-ols were studied by the in vitro experiments and RNA sequencing analysis. These flavan-3-ols showed inhibitory effects on the secretion of pro-inflammation cytokines including interleukin-1β (IL-1β), IL-6, and tumor necrosis factor–α (TNF-α), as well as inhibiting the inflammation responses through down-regulating the gene transcriptions closely related to PI3K-Akt signaling pathway and TNF signaling pathway. The results suggested that these newly synthesized flavan-3-ols have the potential to be lead compounds for anti-inflammatory drugs.
- 3 June 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (22) , eabm9603
Open AccessAsymmetric synthesis of flavanols via Cu-catalyzed kinetic resolution of chromenes and their anti-inflammatory activity
Flavanols are privileged heterocyclic compounds in medicinal chemistry. It is notable to develop an efficient and straightforward protocol for accessing chiral flavanols with precise control of the stereocenters. Here, a highly efficient kinetic resolution of chromenes was reported via Cu-catalyzed asymmetric hydroboration. This previously unidentified approach features a one-step synthesis of chiral flavan-3-ols containing two vicinal stereogenic centers via a highly efficient kinetic resolution ( s factor up to 1060, >99% ee for most products). In addition, the anti-inflammation effects of these diversified flavan-3-ols were studied by the in vitro experiments and RNA sequencing analysis. These flavan-3-ols showed inhibitory effects on the secretion of pro-inflammation cytokines including interleukin-1β (IL-1β), IL-6, and tumor necrosis factor–α (TNF-α), as well as inhibiting the inflammation responses through down-regulating the gene transcriptions closely related to PI3K-Akt signaling pathway and TNF signaling pathway. The results suggested that these newly synthesized flavan-3-ols have the potential to be lead compounds for anti-inflammatory drugs.
- Open Access
- 7 July 2021
- Published by Royal Society of Chemistry (RSC) in Molecular Systems Design & Engineering
- Vol. 6 (8) , 566-593
Bioinspired micro/nanomotors towards a self-propelled noninvasive diagnosis and treatment of cancer
This article reviews the bioinspired design and characterization techniques of the different types of micro/nanomotors and their biomedical applications in cancer diagnosis and treatment.
- 7 July 2021
- Published by Royal Society of Chemistry (RSC) in Molecular Systems Design & Engineering
- Vol. 6 (8) , 566-593
Open AccessBioinspired micro/nanomotors towards a self-propelled noninvasive diagnosis and treatment of cancer
This article reviews the bioinspired design and characterization techniques of the different types of micro/nanomotors and their biomedical applications in cancer diagnosis and treatment.
- 25 May 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (55) , 7573-7576
Enantioselective synthesis of indole derivatives by Rh/Pd relay catalysis and their anti-inflammatory evaluation
An efficient Rh/Pd relay catalyzed intermolecular and cascade intramolecular hydroamination for the synthesis of exclusive trans 1-indolyl dihydronaphthalenols (up to 88% yield, 99% ee) is described under mild conditions. Moreover, the in silico and in vitro screening showed that the novel 1-indolyl dihydronaphthalenol products are potent lead compounds for treating inflammation disease.
- 25 May 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (55) , 7573-7576
Enantioselective synthesis of indole derivatives by Rh/Pd relay catalysis and their anti-inflammatory evaluation
An efficient Rh/Pd relay catalyzed intermolecular and cascade intramolecular hydroamination for the synthesis of exclusive trans 1-indolyl dihydronaphthalenols (up to 88% yield, 99% ee) is described under mild conditions. Moreover, the in silico and in vitro screening showed that the novel 1-indolyl dihydronaphthalenol products are potent lead compounds for treating inflammation disease.